# CAP-CMV

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cap-cmv

- Industry: Pharmaceuticals
- Headquarters: Cologne, Germany
- Total disclosed funding: $1.1M
- Latest round: Series A (Feb 24, 2014)
- Investors on record: 4

## About

Founded in 2013 and based in Cologne, Germany CAP-CMV operates as Pharmaceuticals company developed a novel vaccine protecting against human Cytomegalovirus (HCMV) infection.

## Funding rounds

- Series A, Feb 24, 2014, $1.1M — KfW Banking Group, Creathor Ventures, NRW Bank, Peppermint VenturePartners

## Investors

- KfW Banking Group — Series A
- Creathor Ventures (https://capitalatlas.ai/funds/creathor-ventures) — Series A
- NRW Bank — Series A
- Peppermint VenturePartners (https://capitalatlas.ai/funds/peppermint-venturepartners) — Series A